Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1512707

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1512707

Medical Disposable Market : Market Size & Forecast, 2024 - 2032

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The medical disposable market is anticipated to reach over USD 2142.80 billion by 2032 according to a new research published by Polaris Market Research. In 2023, the drug delivery dominated the worldwide medical disposable industry. Asia-Pacific is anticipated to be the leading contributor to the global market revenue in 2023. The upward momentum of medical disposable in the hospitals, outpatient facility and other healthcare providers. The medical disposable market is primarily driven by increasing number of elderly populations, increasing need to limit the causes of infection, better performance, cost reliability, shelf life, and material. The reusable devices are considered to be relatively inexpensive in many different types, and increasing volume of production by the key players globally would also influence the market growth in the coming years.

Increasing number of technologically advanced products, and continuous research and development to also drive the market growth. Furthermore, increasing awareness in the patients for the use of medical disposable devices to also boost the market growth in the coming years. Also, increasing number of chronic diseases across the globe would also boost the market growth in the coming years.

Based on the product type the medical disposable market is segmented as Wound Management, Drug Delivery, Dialysis, Nonwoven Incontinence, Respiratory Supplies, Diagnostic and Laboratory, and Sterilization. Similarly, on the basis of raw material, the market is segmented as Paper and Paperboard, Plastic Resin, Nonwoven Material, Metals, Glass, and Rubber. Plastic Resin is expected to be the fastest growing segment owning to its various application. End user for the medical disposable devices include Hospitals, Outpatient/Primary Care Facilities, and Home Healthcare.

North America generated the highest revenue in the Medical Disposable market in 2023, and is expected to be the leading region globally during the forecast period. Increasing demand healthcare facilities, increasing number of geriatric populations, and continuous mergers and acquisitions of the key players in the U.S. and Canada. Asia Pacific to also boost the market growth in coming years. The developing healthcare infrastructure of the countries in this region to be the major factor promoting the growth of this market during the forecast period.

The key players operating in the Medical Disposable market include Johnson & Johnson Services, Inc., 3M, Abbott Laboratories, Medtronic Plc., B. Braun Melsungen AG, Bayer AG, Smith and Nephew Plc., Medline Industries, Inc., Cardinal Health, and Becton, Dickinson & Company. The industry participants launch novel products with collaboration and partnership agreements with other companies to innovate and launch new products to meet the increasing needs and requirements of consumers.

Product Code: PM1572

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research Methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-away
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market Definition
  • 2.2. Market Segmentation

3. Medical Disposable Market Insights

  • 3.1. Medical disposable - Industry snapshot
  • 3.2. Medical disposable - Ecosystem analysis
  • 3.3. Medical disposable Market Dynamics
    • 3.3.1. Medical disposable - Market Forces
      • 3.3.1.1. Medical disposable Market Driver Analysis
      • 3.3.1.2. Medical disposable Market Restraint/Challenges analysis
      • 3.3.1.3. Medical disposable Market Opportunity Analysis
  • 3.4. Industry analysis - Porter's five force
    • 3.4.1. Bargaining power of supplier
    • 3.4.2. Bargaining power of buyer
    • 3.4.3. Threat of substitute
    • 3.4.4. Threat of new entrant
    • 3.4.5. Degree of competition
  • 3.5. Medical disposable Market PEST Analysis
  • 3.6. Medical disposable Market Value Chain Analysis
  • 3.7. Medical disposable Industry Trends
  • 3.8. Competitive Ranking Analysis

4. Medical Disposable Market Size and Forecast by Treatment Type, 2019-2032

  • 4.1. Key Findings
  • 4.2. Wound Management
  • 4.3. Drug Delivery
  • 4.4. Dialysis
  • 4.5. Nonwoven Incontinence
  • 4.6. Respiratory Supplies
  • 4.7. Diagnostic and Laboratory
  • 4.8. Sterilization

5. Medical Disposable Market Size and Forecast by Raw Material Type, 2019-2032

  • 5.1. Key Findings
  • 5.2. Paper and Paperboard
  • 5.3. Plastic Resin
  • 5.4. Nonwoven Material
  • 5.5. Metals
  • 5.6. Glass
  • 5.7. Rubber

6. Medical Disposable Market Size and Forecast by End Use, 2019-2032

  • 6.1. Key Findings
  • 6.2. Hospitals
  • 6.3. Outpatient/Primary Care Facilities
  • 6.4. Home Healthcare

7. Medical Disposable Market Size and Forecast by Region, 2019-2032

  • 7.1. Key Findings
  • 7.2. North America
    • 7.2.1. U. S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. UK
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Asia-Pacific
    • 7.4.1. China
    • 7.4.2. India
    • 7.4.3. Japan
    • 7.4.4. Singapore
    • 7.4.5. Malaysia
    • 7.4.6. Australia
    • 7.4.7. Rest of Asia-Pacific
  • 7.5. Latin America
    • 7.5.1. Mexico
    • 7.5.2. Brazil
    • 7.5.3. Argentina
    • 7.5.4. Rest of LATAM
  • 7.6. Middle East & Africa

8. Company Profiles

  • 8.1. Johnson & Johnson Services, Inc.
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Developments
  • 8.2. 3M
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Developments
  • 8.3. Abbott Laboratories.
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Developments
  • 8.4. Braun Melsungen AG
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Developments
  • 8.5. Bayer AG
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Developments
  • 8.6. Smith and Nephew Plc
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Developments
  • 8.7. Medline Industries, Inc.
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Developments
  • 8.8. Cardinal Health.
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Developments
  • 8.9. Becton, Dickinson & Company
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Developments
  • 8.10. Medtronic Plc.gk
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!